How would you approach the management of a patient with oligometastatic NSCLC characterized by a LUL mass and a solitary adrenal metastasis, assuming a good performance status?
Medical Oncologist
Induction chemotherapy (platinum-doublet x3 cycles) followed by lobectomy, mediastinal lymph node dissection, and adrenalectomy if no progression after induction chemotherapy.Reference: Gomez DR et al, Lancet Oncology 2016
Comments
Medical Oncologist at University of Colorado Cancer Center Agree but would not proceed to lobectomy or adrena...
Agree but would not proceed to lobectomy or adrena...